Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06353386
Status:
RECRUITING
Last Update Posted:
2024-06-27
First Post:
2024-04-03
Brief Title:
Substudy 01A Safety and Efficacy of Opevesostat MK-5684-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer mCRPC MK-5684-01A
Sponsor:
Organization:
Merck Sharp Dohme LLC